Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: Do tirofiban and ReoPro give similar efficacy outcomes trial (TARGET) 1-year follow-up

Marco Roffi, David J. Moliterno, Bernhard Meier, Eric R. Powers, Cindy L. Grines, Peter M. DiBattiste, Howard C. Herrmann, Michel Bertrand, Katherine E. Harris, Laura A. Demopoulos, Eric J. Topol

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: Do tirofiban and ReoPro give similar efficacy outcomes trial (TARGET) 1-year follow-up'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology